Ghosh Abhishek, Kathiravan Sanjana, Singh Pranshu, Sharma Babita, Gupta Surabhi, Pillai Renjith R
From the Drug Deaddiction and Treatment Centre, Department of Psychiatry, Postgraduate Institute of Medical Education and Research, Chandigarh, India (AG); Department of Psychiatry, Postgraduate Institute of Medical Education and Research, Chandigarh, India (SK, BS, SG); Department of Psychiatry, All India Institute of Medical Sciences, Jodhpur, India (PS); Psychiatric Social Work, Drug Deaddiction and Treatment Centre, Department of Psychiatry, Postgraduate Institute of Medical Education and Research, Chandigarh India (RRP).
J Addict Med. 2023;17(2):e78-e86. doi: 10.1097/ADM.0000000000001058. Epub 2022 Aug 24.
Multiple substance use is a common but underrecognized problem in patients on opioid agonist treatment (OAT). Co-occurring substance misuse is associated with poor clinical and psychosocial outcomes. We aimed ( a ) to determine the effect of screening and brief intervention (SBI) for substance misuse in people on OAT and (b) to qualitatively summarize the implementation of SBI.
We performed a systematic review of clinical trials on the efficacy of SBI for alcohol and drug misuse in participants on OAT. We searched 5 electronic databases and included published studies and unpublished trials. We measured the standardized mean difference in substance risk scores before and after intervention. We also estimated the standardized mean difference in alcohol consumption per day before and after intervention.
We included a total of 8 studies; 5 of these were included in the meta-analysis, and all were reviewed for narrative synthesis. We observed a significant change in the pre-post brief intervention substance risk scores with a medium effect size (Hedges g = 0.752, 95% confidence interval, 0.405-1.099). Sensitivity analyses with different pretest-posttest correlations did not change our result. Modest effects of SBI were found in reducing both alcohol and illicit drug risk scores, and among the population on methadone and buprenorphine treatment. We also observed a significant decrease in alcohol consumption per day 3 months after SBI. Studies showed a limited and incomplete screening for substance misuse and delivery of brief intervention in OAT settings.
Screening and brief intervention may be a potential treatment for co-occurring substance misuse among patients on OAT.
多种物质使用是接受阿片类激动剂治疗(OAT)的患者中常见但未得到充分认识的问题。同时存在的物质滥用与不良的临床和心理社会结局相关。我们旨在(a)确定对接受OAT治疗的人群进行物质滥用筛查和简短干预(SBI)的效果,以及(b)定性总结SBI的实施情况。
我们对关于SBI对接受OAT治疗的参与者中酒精和药物滥用疗效的临床试验进行了系统评价。我们检索了5个电子数据库,纳入了已发表的研究和未发表的试验。我们测量了干预前后物质风险评分的标准化均值差异。我们还估计了干预前后每日酒精消费量的标准化均值差异。
我们共纳入了8项研究;其中5项纳入了荟萃分析,所有研究均进行了叙述性综合评价。我们观察到简短干预前后物质风险评分有显著变化,效应量中等(Hedges g = 0.752,95%置信区间,0.405 - 1.099)。不同前后测相关性的敏感性分析未改变我们的结果。在降低酒精和非法药物风险评分方面,以及在接受美沙酮和丁丙诺啡治疗的人群中,发现SBI有适度效果。我们还观察到SBI后3个月每日酒精消费量显著下降。研究表明,在OAT环境中,对物质滥用的筛查有限且不完整,简短干预的实施也不充分。
筛查和简短干预可能是治疗接受OAT治疗患者中同时存在的物质滥用的一种潜在方法。